How to apply
Call on sex- and gender-related research projects in RMDs
Many Rheumatic Musculoskeletal Diseases (RMDs) show gender differences with respect to their prevalence, clinical manifestation and disease course. Furthermore, sex hormones and other sex-dependent mediators are known to differentially affect the cells of the immune system as well as the musculoskeletal system, thereby affecting the pathogenesis of RMDs. In addition, sex- and or gender-related issues may affect treatment decisions and the general management of RMDs. To date, little is known about the mechanisms of how sex and gender influence RMDs.
FOREUM seeks to support projects in the following areas:
- Influence of sex/gender on processes that influence the pathogenesis of RMDs
- Sex-/gender-related factors that impact on the disease course, prognosis and outcomes of RMDs
- The role of gender in optimizing the treatment of RMDs
- Sex/gender-related differences and disparities in the management of RMDs
FOREUM primarily encourages collaboration across Europe and therefore requires multi-center project applications involving partners from at least three different countries. Any given institution shall be allowed to lead on only one application. However, that institution, or its staff may participate in other projects as collaborators.
Closing date for letter of intent: 10 September 2019
Decisions on letter of intent announced: 10 October 2019
Closing date for full proposals: 30 November 2019
Decisions on full proposals announced: 1 February 2020